AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion - statnews.com
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks
Search Group
Share To
Comments
About Screade
Screade® Inc. version 1c21fe3, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments